GENOWAY (EPA:ALGEN) | WebDisclosure

Basculer en Français

10153	Companies
208571	Keywords
138663	Articles
110538	Press releases

Home
Companies
GENOWAY

BRIEF

published on 03/30/2026 at 18:50, 2 days 23 hours ago

GenOway: Solid 2025 annual results despite a slight decrease in revenue

EBITDA GenOway Route50+ Growth 2026 2025 Results
BRIEF

published on 03/30/2026 at 18:50, 2 days 23 hours ago

GenOway : Résultats annuels 2025 solides malgré une légère baisse de chiffre d'affaires

EBITDA GenOway Route50+ Croissance 2026 Résultats 2025
PRESS RELEASE

published on 03/30/2026 at 18:45, 2 days 23 hours ago

Solides résultats annuels 2025 avec une marge d'EBITDA de 21% en progression - Confirmation de l'objectif d'une croissance organique à deux chiffres sur l'exercice 2026
genOway publie ses résultats annuels 2025 avec une marge d'EBITDA de 21% en progression, confirmant une croissance organique à deux chiffres pour 2026. Déploiement réussi de la nouvelle organisation commerciale et lancement de nouvelles gammes de modèles

Résultats Annuels Croissance Organique Marge EBITDA GenOway Nouvelles Gammes
BRIEF

published on 03/25/2026 at 18:05, 8 days ago

GenOway establishes a presence in Japan with a new subsidiary

Life Sciences International Expansion Japan Market Preclinical Research GenOway Japan
BRIEF

published on 03/25/2026 at 18:05, 8 days ago

GenOway s'implante au Japon avec une nouvelle filiale

Recherche Préclinique Expansion Internationale Sciences De La Vie GenOway Japan Japon Marché
PRESS RELEASE

published on 03/25/2026 at 18:00, 8 days ago

genOway poursuit son développement international : création de sa filiale genOway Japan pour pénétrer plus efficacement le 3ème marché mondial de la recherche préclinique et viser 5 à 10 M EUR de revenus dans le cadre du plan Route50+data
Nomination de Dr. Hideki Hanaoka en tant que Directeur général de genOway Japan et Présidence du Conseil d'administration confiée à Philippe Fauchet. genOway annonce la création de sa filiale genOway Japan pour développer les ventes de modèles précliniques en immuno-oncologie au Japon

GenOway Modèles Précliniques GenOway Japan Hideki Hanaoka Philippe Fauchet
BRIEF

published on 01/26/2026 at 18:05, 2 months 7 days ago

Genoway anticipates dynamic growth in 2026

International Expansion GenOway Growth 2026 ROUTE50+DATA Preclinical Solutions
BRIEF

published on 01/26/2026 at 18:05, 2 months 7 days ago

Genoway envisage une croissance dynamique en 2026

Expansion Internationale GenOway Croissance 2026 Solutions Précliniques ROUTE50+DATA
PRESS RELEASE

published on 01/26/2026 at 18:00, 2 months 7 days ago

Succès de la nouvelle organisation commerciale avec un 2nd semestre stable - Chiffre d'affaires annuel de 21 M EUR - Bonne visibilité sur le 1er semestre 2026 - Croissance organique supérieure à +10% visée sur l'exercice
genOway publie son chiffre d'affaires 2025 en léger repli de -5%, malgré des plans ambitieux et une nouvelle activité dans la data prédictive, anticipant une croissance organique de +10% en 2026

Chiffre D'affaires Croissance Organique Pharmaceutique Data Science GenOway
BRIEF

published on 01/19/2026 at 18:35, 2 months 13 days ago

Half-year review of the liquidity contract for genOway as of December 31, 2025

Liquidity Contract Biotechnology PORTZAMPARC Euronext Growth GenOway

1 2 ... 5

Accesswire

Published on 04/02/2026 at 15:00, 3 hours 29 minutes ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 3 hours 49 minutes ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 3 hours 59 minutes ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/02/2026 at 14:10, 4 hours 19 minutes ago

Side-by-Side Conference Hosts Close to 800 Participants in Malta to Advance Women's Health Care
Published on 04/02/2026 at 14:00, 4 hours 29 minutes ago

Electrovaya Collaborates on U.S. Department of Energy-Funded Project to Advance Energy Storage for Critical Infrastructure

View all ACCESSWIRE

EQS Group

Published on 04/02/2026 at 17:45, 44 minutes ago

Minority Shareholders of DKSH Holdings (Malaysia) Berhad Reject Take-Over Offer by DKSH Holding Ltd. at Extraordinary General Meeting
Published on 04/02/2026 at 17:28, 1 hour 1 minute ago

hep global GmbH recommends approving the jointly agreed, amended resolution proposal of SdK in the voting without a meeting from 12 to 14 April 2026
Published on 04/02/2026 at 17:27, 1 hour 2 minutes ago

DSH-Director/PDMR Shareholding
Published on 04/02/2026 at 16:10, 2 hours 19 minutes ago

The Adelaïde Group continued on its growth path in 2025 and consolidated the foundations of its European expansion
Published on 04/02/2026 at 15:32, 2 hours 56 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc

Les Echos

Published on 04/02/2026 at 18:22, 7 minutes ago

TF1 - Déclaration mensuelle des actions et droits de vote - Mars 2026
Published on 04/02/2026 at 18:22, 7 minutes ago

TF1 - Monthly disclosure of the total number of shares and voting rights - March 2026
Published on 04/02/2026 at 18:00, 29 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of March 27, 2026
Published on 04/02/2026 at 18:00, 29 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 27 mars 2026
Published on 04/02/2026 at 18:00, 29 minutes ago

ICADE – PR – Availability of the 2025 URD

View all LES ECHOS COMFI WIRE